A randomised, controlled, double-blind, cross-over pilot study assessing the effects of spironolactone, losartan and their combination on heart rate variability and QT dispersion in patients with chronic heart failure
- A. Shehab
- , A. A. Elnour
- , A. D. Struthers
Research output: Contribution to journal › Article › peer-review
18
Link opens in a new tab
Citations
(Scopus)